Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MRTX1133
i
Other names:
MRTX1133, MRTX-1133, MRTX 1133
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(8)
News
Trials
Company:
BMS
Drug class:
KRAS G12D inhibitor
Related drugs:
‹
KS-58 (3)
RMC-9805 (2)
QTX3034 (1)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
KS-58 (3)
RMC-9805 (2)
QTX3034 (1)
QTX3046 (1)
YL-17231 (1)
HRS-4642 (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12D
Colorectal Cancer
KRAS G12D
Colorectal Cancer
MRTX1133
Sensitive: C2 – Inclusion Criteria
MRTX1133
Sensitive
:
C2
MRTX1133
Sensitive: C2 – Inclusion Criteria
MRTX1133
Sensitive
:
C2
KRAS G12D
Pancreatic Cancer
KRAS G12D
Pancreatic Cancer
MRTX1133
Sensitive: C2 – Inclusion Criteria
MRTX1133
Sensitive
:
C2
MRTX1133
Sensitive: C2 – Inclusion Criteria
MRTX1133
Sensitive
:
C2
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
MRTX1133 + BI 894999 + dBET6
Sensitive: D – Preclinical
MRTX1133 + BI 894999 + dBET6
Sensitive
:
D
MRTX1133 + BI 894999 + dBET6
Sensitive: D – Preclinical
MRTX1133 + BI 894999 + dBET6
Sensitive
:
D
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
afatinib + MRTX1133
Sensitive: D – Preclinical
afatinib + MRTX1133
Sensitive
:
D
afatinib + MRTX1133
Sensitive: D – Preclinical
afatinib + MRTX1133
Sensitive
:
D
KRAS G12D
Colorectal Cancer
KRAS G12D
Colorectal Cancer
cetuximab + MRTX1133
Sensitive: D – Preclinical
cetuximab + MRTX1133
Sensitive
:
D
cetuximab + MRTX1133
Sensitive: D – Preclinical
cetuximab + MRTX1133
Sensitive
:
D
KRAS G12D
Pancreatic Adenocarcinoma
KRAS G12D
Pancreatic Adenocarcinoma
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
KRAS G12D
Multiple Myeloma
KRAS G12D
Multiple Myeloma
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
MRTX1133
Sensitive: D – Preclinical
MRTX1133
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login